Fundamentals of HIV Medicine 2019: CME EditionW. David Hardy Oxford University Press, 2019 - 584 Seiten The essential work in HIV for providers and pharmacists, updated for 2019 Includes CME access code for 2019 AAHIVS, AAHIVE, or AAHIVP accreditation Assembled by the leading educational organization in HIV medicine, AAHIVM's Fundamentals of HIV Medicine 2019 is an end-to-end clinical resource for the treatment of individuals with HIV/AIDS. It offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, and other professionals working in the care of HIV patients. Along with updates to the classic domains of HIV medicine, this new edition features expanded coverage of emerging topics, including: behavioral and therapeutic interventions to HIV prevention; updates on the pursuit of a cure; new DHHS and IAS guidelines and their clinical implications; and the myriad issues around aging with HIV. Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2019 is a must-have for health professionals across HIV care, treatment, and prevention. Note: This edition includes a login for online CME questions and accreditation |
Inhalt
1 Epidemiology and the Spread of HIV | 1 |
2 The Origin Evolution and Epidemiology of HIV1 and HIV2 | 15 |
3 Mechanisms of HIV Transmission | 21 |
4 HIV Transmission Prevention | 25 |
5 Immunology | 49 |
6 HIV Cure Strategies | 59 |
7 HIV Testing and Counseling | 67 |
8 Laboratory Testing Strategies Detection and Diagnosis | 73 |
28 Antiretroviral Therapy for Children and Newborns | 287 |
29 Immunosuppressants and Antiretroviral Therapy in HIVPositive Transplant Patients | 297 |
30 Understanding and Managing Antineoplastic and Antiretroviral Therapy | 301 |
31 Substance Abuse in HIV Populations | 309 |
32 Understanding the Use of Antiretrovirals in the Aging Patient | 317 |
33 Opportunistic Infections | 323 |
34 Malignancies in HIV | 337 |
35 Dermatologic Complications | 379 |
9 The Medical History and Physical Examination of the Patient with HIV | 83 |
10 Initial Laboratory Evaluation and Risk Stratification of the Patient with HIV | 87 |
11 Recognition of Acute and Advanced HIV Infection | 91 |
12 Health Maintenance | 97 |
13 Issues in Specific Patient Populations | 115 |
14 Complementary and Alternative MedicineIntegrative Medicine Approaches | 157 |
15 HIV Care Coordination | 175 |
16 The Pharmacists Role in Caring for HIVPositive Individuals | 183 |
17 The Role of the Physician Assistant and the Nurse Practitioner in Caring for Persons Living with HIV | 189 |
18 Hospice and Palliative Care in Advanced HIV Disease | 199 |
19 HIV Virology | 205 |
20 Principles of Applied Clinical Pharmacokinetics and Pharmacodynamics in Antiretroviral Therapy | 219 |
21 Classes of Antiretrovirals | 225 |
What to Start With | 239 |
23 HIV1 Resistance to Antiretroviral Drugs | 245 |
24 Managing the Patient with MultidrugResistant HIV | 257 |
25 Future Antiretrovirals ImmuneBased Strategies and Therapeutic Vaccines | 261 |
26 Solid Organ Transplantation in Persons Living with HIV | 275 |
27 Antiretroviral Therapy in Pregnant Women | 281 |
36 Endocrine and Metabolic Disorders | 391 |
Respiratory Complications | 399 |
38 Psychiatric Illness and Treatment in HIV Populations | 403 |
39 Neurological Effects of HIV Infection | 413 |
40 HIV and Hepatitis Coinfection | 433 |
41 Ocular Complications | 447 |
42 Cardiovascular Disease | 453 |
43 Renal Complications | 469 |
44 Body Composition Changes Frailty and Musculoskeletal Complications of HIV | 481 |
45 Sexually Transmitted Diseases | 487 |
46 HIV and Bone Health | 493 |
47 HIVAssociated Lipodystrophy and Lipoatrophy | 505 |
48 Immune Reconstitution Inflammatory Syndrome IRIS | 513 |
49 US Healthcare Systems HIV Programs and Coverage Policy Issues | 519 |
50 Legal Issues | 525 |
51 Research Design and Analysis | 541 |
52 Ethical Conduct of Clinical Trials Institutional Review Boards Informed Consent and Financial Conflicts of Interest | 545 |
| 549 | |
